In the brains of AD patients, endogenous PP2A inhibitors, I1PP2A, I2PP2A and CIP2A [359], are colocalized in the cytoplasm with PP2A within neurons, and increasing these inhibitors suppresses PP2A activity and induces tau hyperphosphorylation. The gene discussed is PTPA; the disease is Alzheimer disease.